DiagnostIQ is a young startup company based in Budapest, founded in 2021 with the mission of delivering innovative, breakthrough services in the field of medical diagnostics. We aim to achieve this through the development of "smart" diagnostic solutions that enhance the efficiency of laboratory diagnostics, general diagnostics, and imaging diagnostics, offering substantial support to medical specialists and healthcare institutions in improving the effectiveness of daily clinical practice. To improve the efficiency and interpretability of laboratory diagnostics, our team at DiagnostIQ Ltd. is developing a solution called "OKOSLELET" (Smart Medical Report). This tool is capable of performing complex risk assessments for both rare and common diseases based on routine blood test results and presenting these in a clear and understandable format for both patients and healthcare professionals. In addition to the effective interpretation of laboratory results, our system can also identify potential directions for further testing, diagnostics, and medical interventions, thereby contributing to the expansion and advancement of digital healthcare.
The Ai|Life SMART MEDICAL REPORT is a revolutionary innovation capable of estimating the risk of 14 disease groups from a single blood test result using artificial intelligence. Beyond the data found in a traditional blood test report, the SMART MEDICAL REPORT provides insights into possible causes of abnormal values and potential diseases, along with estimated probabilities.How? The *artificial intelligence behind the SMART MEDICAL REPORT analyzes the risk of individual diseases by comparing patterns in your data with hundreds of millions of data points from hundreds of thousands of other patients.
*The SMART MEDICAL REPORT utilizes machine learning based on large-scale health data. It aligns with the European Union's strategy outlined in COM(2018) 795, adopted in Brussels on 7 December 2018, specifically section 2.5 and its second paragraph, which identifies this as a type of artificial intelligence.This approach can uncover diseases that have not yet caused symptoms and may not be apparent from deviations in standard reference values. The SMART MEDICAL REPORT can guide healthcare providers by highlighting conditions that might otherwise only be diagnosed years later or remain undetected. Through regular screenings, these conditions can potentially be identified at an early stage, providing patients with better prospects for effective treatment and recovery.
The SMART MEDICAL REPORT is capable of estimating the risk of the following 14 disease groups. Currently, the diagnostic risk assessment of the SMART MEDICAL REPORT is primarily optimized for chronic and often difficult-to-diagnose disease groups and conditions. However, it is also capable of estimating the presence of acute, rapidly progressing conditions (e.g., acute liver diseases).The SMART MEDICAL REPORT assesses the risk of cancer only when analyzing the cancer disease group, which is available in the SMART MEDICAL REPORT "Premium" risk assessment package. This feature is not included in other packages. The premium package can be ordered at this link: https://synlab.hu/okoslelet-premium-kockazatbecslo-csomag/
Innovation
